Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edicotinib in active rheumatoid arthritis
NCT01597739Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of edicotinib in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Jul 2012; status: completed.
02
Drugs
edicotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01597739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597739.